Ultima Vez Modificado: 28 de mayo del 2008
Aug 23, 2015
Small study showed 100 percent sensitivity and 90.9 percent specificity
Oct 22, 2010
Study finds high sensitivity for early melanomas, borderline lesions; specificity better than clinicians'
Oct 30, 2015
Increased risk with methotrexate, and for anti-TNF drugs in conjunction with methotrexate